DNA methylation dynamics in the hepatic CYP3A4 gene promoter

Biochimie

Volumn 94, Issue 11, 2012, Pages 2338-2344

  Kacevska, Marina ^a   Ivanov, Maxim ^a   Wyss, Annika ^a   Kasela, Silva ^b   Milani, Lili ^b   Rane, Anders ^a   Ingelman Sundberg, Magnus ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF TARTU   (Estonia)

Author keywords

CYP3A4; DNA methylation; Epigenetics

Indexed keywords

BISULFITE; CCAAT ENHANCER BINDING PROTEIN; CYTOCHROME P450 3A4; CYTOCHROME P450 3A7; HEPATOCYTE NUCLEAR FACTOR 4ALPHA;

ADULT; ARTICLE; BINDING SITE; CPG ISLAND; DNA METHYLATION; DRUG RESPONSE; EPIGENETICS; FEMALE; FETUS; GENE CONTROL; GENE EXPRESSION; GENE SEQUENCE; HISTONE MODIFICATION; HUMAN; HUMAN TISSUE; LIVER; LIVER DEVELOPMENT; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION;

ADULT; CPG ISLANDS; CYTOCHROME P-450 CYP3A; DNA METHYLATION; ENHANCER ELEMENTS, GENETIC; FEMALE; FETUS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; INFANT; LIVER; MALE; PROMOTER REGIONS, GENETIC;

EID: 84867402748     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2012.07.013     Document Type: Article

References (41)

1. P.B. Danielson The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans Curr. Drug Metab. 3 2002 561 597
2. D.W. Nebert, and D.W. Russell Clinical importance of the cytochromes P450 Lancet 360 2002 1155 1162
3. F.P. Guengerich Cytochromes P450, drugs, and diseases Mol. Interv. 3 2003 194 204
4. J.K. Lamba, Y.S. Lin, E.G. Schuetz, and K.E. Thummel Genetic contribution to variable human CYP3A-mediated metabolism Adv. Drug Deliv. Rev. 54 2002 1271 1294
5. T. Shimada, H. Yamazaki, M. Mimura, Y. Inui, and F.P. Guengerich Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians J. Pharmacol. Exp. Ther. 270 1994 414 423
6. A. Westlind, L. Lofberg, N. Tindberg, T.B. Andersson, and M. Ingelman-Sundberg Interindividual differences in hepatic expression of CYP3A4: relationship to genetic polymorphism in the 5'-upstream regulatory region Biochem. Biophys. Res. Commun. 259 1999 201 205
7. A. Westlind-Johnsson, S. Malmebo, A. Johansson, C. Otter, T.B. Andersson, I. Johansson, R.J. Edwards, A.R. Boobis, and M. Ingelman-Sundberg Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism Drug Metab. Dispos. 31 2003 755 761
8. M.A. Felmlee, H.K. Lon, F.J. Gonzalez, and A.M. Yu Cytochrome P450 expression and regulation in CYP3A4/CYP2D6 double transgenic humanized mice Drug Metab. Dispos. 36 2008 435 441
9. R. Wolbold, K. Klein, O. Burk, A.K. Nussler, P. Neuhaus, M. Eichelbaum, M. Schwab, and U.M. Zanger Sex is a major determinant of CYP3A4 expression in human liver Hepatology 38 2003 978 988
10. H. Satsu, Y. Hiura, K. Mochizuki, M. Hamada, and M. Shimizu Activation of pregnane X receptor and induction of MDR1 by dietary phytochemicals J. Agric. Food Chem. 56 2008 5366 5373
11. P. He, M.H. Court, D.J. Greenblatt, and L.L. von Moltke Human pregnane X receptor: genetic polymorphisms, alternative mRNA splice variants, and cytochrome P450 3A metabolic activity J. Clin. Pharmacol. 46 2006 1356 1369
12. J. Lamba, V. Lamba, and E. Schuetz Genetic variants of PXR (NR1I2) and CAR (NR1I3) and their implications in drug metabolism and pharmacogenetics Curr. Drug Metab. 6 2005 369 383
13. J. Lamba, V. Lamba, S. Strom, R. Venkataramanan, and E. Schuetz Novel single nucleotide polymorphisms in the promoter and intron 1 of human pregnane X receptor/NR1I2 and their association with CYP3A4 expression Drug Metab. Dispos. 36 2008 169 181
14. V. Ozdemir, W. Kalow, B.K. Tang, A.D. Paterson, S.E. Walker, L. Endrenyi, and A.D. Kashuba Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method Pharmacogenetics 10 2000 373 388
15. S. Choudhuri From Waddington's epigenetic landscape to small noncoding RNA: some important milestones in the history of epigenetics research Toxicol. Mech. Methods 21 2011 252 274
16. D. Mohtat, and K. Susztak Fine tuning gene expression: the epigenome Semin. Nephrol. 30 2010 468 476
17. M. Kacevska, M. Ivanov, and M. Ingelman-Sundberg Perspectives on epigenetics and its relevance to adverse drug reactions Clin. Pharmacol. Ther. 89 2011 902 907
18. L.O. Dannenberg, and H.J. Edenberg Epigenetics of gene expression in human hepatoma cells: expression profiling the response to inhibition of DNA methylation and histone deacetylation BMC Genomics 7 2006 181
19. W. Habano, T. Gamo, J. Terashima, T. Sugai, K. Otsuka, G. Wakabayashi, and S. Ozawa Involvement of promoter methylation in the regulation of pregnane X receptor in colon cancer cells BMC Cancer 11 2011 81
20. Y. Li, Y. Cui, S.N. Hart, C.D. Klaassen, and X.B. Zhong Dynamic patterns of histone methylation are associated with ontogenic expression of the Cyp3a genes during mouse liver maturation Mol. Pharmacol. 75 2009 1171 1179
21. C. Rodriguez-Antona, M. Jande, A. Rane, and M. Ingelman-Sundberg Identification and phenotype characterization of two CYP3A haplotypes causing different enzymatic capacity in fetal livers Clin. Pharmacol. Ther. 77 2005 259 270
22. C.P. Martinez-Jimenez, M.J. Gomez-Lechon, J.V. Castell, and R. Jover Transcriptional regulation of the human hepatic CYP3A4: identification of a new distal enhancer region responsive to CCAAT/enhancer-binding protein beta isoforms (liver activating protein and liver inhibitory protein) Mol. Pharmacol. 67 2005 2088 2101
23. B. Goodwin, E. Hodgson, and C. Liddle The orphan human pregnane X receptor mediates the transcriptional activation of CYP3A4 by rifampicin through a distal enhancer module Mol. Pharmacol. 56 1999 1329 1339
24. B. Goodwin, E. Hodgson, D.J. D'Costa, G.R. Robertson, and C. Liddle Transcriptional regulation of the human CYP3A4 gene by the constitutive androstane receptor Mol. Pharmacol. 62 2002 359 365
25. H. Tegude, A. Schnabel, U.M. Zanger, K. Klein, M. Eichelbaum, and O. Burk Molecular mechanism of basal CYP3A4 regulation by hepatocyte nuclear factor 4alpha: evidence for direct regulation in the intestine Drug Metab. Dispos. 35 2007 946 954
26. K. Matsumura, T. Saito, Y. Takahashi, T. Ozeki, K. Kiyotani, M. Fujieda, H. Yamazaki, H. Kunitoh, and T. Kamataki Identification of a novel polymorphic enhancer of the human CYP3A4 gene Mol. Pharmacol. 65 2004 326 334
27. A.M. Deaton, and A. Bird CpG islands and the regulation of transcription Genes Dev. 25 2011 1010 1022
28. A. Doi, I.H. Park, B. Wen, P. Murakami, M.J. Aryee, R. Irizarry, B. Herb, C. Ladd-Acosta, J. Rho, S. Loewer, J. Miller, T. Schlaeger, G.Q. Daley, and A.P. Feinberg Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts Nat. Genet. 41 2009 1350 1353
29. A. Meissner, T.S. Mikkelsen, H. Gu, M. Wernig, J. Hanna, A. Sivachenko, X. Zhang, B.E. Bernstein, C. Nusbaum, D.B. Jaffe, A. Gnirke, R. Jaenisch, and E.S. Lander Genome-scale DNA methylation maps of pluripotent and differentiated cells Nature 454 2008 766 770
30. F. Eckhardt, J. Lewin, R. Cortese, V.K. Rakyan, J. Attwood, M. Burger, J. Burton, T.V. Cox, R. Davies, T.A. Down, C. Haefliger, R. Horton, K. Howe, D.K. Jackson, J. Kunde, C. Koenig, J. Liddle, D. Niblett, T. Otto, R. Pettett, S. Seemann, C. Thompson, T. West, J. Rogers, A. Olek, K. Berlin, and S. Beck DNA methylation profiling of human chromosomes 6, 20 and 22 Nat. Genet. 38 2006 1378 1385
31. V. Rishi, P. Bhattacharya, R. Chatterjee, J. Rozenberg, J. Zhao, K. Glass, P. Fitzgerald, and C. Vinson CpG methylation of half-CRE sequences creates C/EBPalpha binding sites that activate some tissue-specific genes Proc. Natl. Acad. Sci. U S A 107 2010 20311 20316
32. B.L. Urquhart, R.G. Tirona, and R.B. Kim Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs J. Clin. Pharmacol. 47 2007 566 578
33. D. Wang, Z. Jiang, Z. Shen, H. Wang, B. Wang, W. Shou, H. Zheng, X. Chu, J. Shi, and W. Huang Functional evaluation of genetic and environmental regulators of p450 mRNA levels PLoS One 6 2011 e24900
34. M. Murray Role of signalling systems in the effects of dietary factors on the expression of mammalian CYPs Expert Opin. Drug Metab. Toxicol. 3 2007 185 196
35. A. Parkinson, D.R. Mudra, C. Johnson, A. Dwyer, and K.M. Carroll The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes Toxicol. Appl. Pharmacol. 199 2004 193 209
36. J.D. Schuetz, D.L. Beach, and P.S. Guzelian Selective expression of cytochrome P450 CYP3A mRNAs in embryonic and adult human liver Pharmacogenetics 4 1994 11 20
37. D. Lacroix, M. Sonnier, A. Moncion, G. Cheron, and T. Cresteil Expression of CYP3A in the human liver-evidence that the shift between CYP3A7 and CYP3A4 occurs immediately after birth Eur. J. Biochem. 247 1997 625 634
38. J.S. Leeder, R. Gaedigk, K.A. Marcucci, A. Gaedigk, C.A. Vyhlidal, B.P. Schindel, and R.E. Pearce Variability of CYP3A7 expression in human fetal liver J. Pharmacol. Exp. Ther. 314 2005 626 635
39. J.A. Williams, B.J. Ring, V.E. Cantrell, D.R. Jones, J. Eckstein, K. Ruterbories, M.A. Hamman, S.D. Hall, and S.A. Wrighton Comparative metabolic capabilities of CYP3A4, CYP3A5, and CYP3A7 Drug Metab. Dispos. 30 2002 883 891
40. J.C. Stevens New perspectives on the impact of cytochrome P450 3A expression for pediatric pharmacology Drug Discov. Today 11 2006 440 445
41. R.N. Hines The ontogeny of drug metabolism enzymes and implications for adverse drug events Pharmacol. Ther. 118 2008 250 267